A carregar...

Differences in Response to Fetal Hemoglobin Induction Therapy in β-Thalassemia and Sickle Cell Disease

Inducers of fetal hemoglobin (HbF) have shown considerable promise in the treatment of sickle cell disease (SCD). However, the same agents have shown less clinical activity in β-thalassemia (β-Thal). To understand the basis of these differences in clinical effectiveness, we compared the effects of b...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Fathallah, Hassana, Taher, Ali, Bazarbachi, Ali, Atweh, George F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2707824/
https://ncbi.nlm.nih.gov/pubmed/19346141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcmd.2009.02.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!